Update on Percutaneous Ablation for Sarcoma

Area of Science:

• Oncology
• Surgical Oncology
• Interventional Radiology

Background:

• Sarcomas are rare cancers requiring diverse treatment strategies.
• Percutaneous thermal ablation presents a minimally invasive approach for managing these tumors.
• Current evidence supports ablation for specific sarcoma subtypes and metastatic disease.

Purpose of the Study:

• To review the current applications and advancements in percutaneous thermal ablation for sarcoma treatment.
• To highlight the role of ablation as an adjunct to traditional therapies like surgery and radiation.
• To discuss emerging ablative modalities and combination therapies.

Main Methods:

• Review of current literature on percutaneous thermal ablation in sarcoma.
• Analysis of safety and efficacy data for various ablation techniques.
• Exploration of novel ablative technologies and combination treatment strategies.

Main Results:

• Percutaneous thermal ablation demonstrates safety and efficacy for local tumor control and palliation in select sarcoma patients.
• Ablation is particularly beneficial for extra-abdominal desmoid fibromatosis and oligometastatic disease.
• Combination therapies (e.g., cryoablation with immunotherapy) and histotripsy are areas of active research.

Conclusions:

• Percutaneous thermal ablation is a valuable tool in the multidisciplinary management of sarcoma.
• While high-level evidence is limited, ablation offers a safe and effective option for local control and pain relief.
• Emerging non-thermal modalities like histotripsy may broaden future treatment possibilities.